Sionna Therapeutics, Inc. SEC filings SION

Sionna Therapeutics, Inc. has 231 filings in SEC EDGAR's recent list, going back to Sep 12, 2024. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.

Sionna Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 21, 2026 —
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
144 Notice of proposed sale Sep 17, 2026 —
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
Sep 14, 2026 Sep 9, 2026
8-K Current report
Other events
Aug 10, 2026 Aug 10, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 9, 2026 Jul 7, 2026
4 Insider transaction Jul 9, 2026 Jul 7, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
144/A Filing Jun 1, 2026 —
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
144 Notice of proposed sale May 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 17, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 20, 2026 —
4 Insider transaction Apr 16, 2026 Apr 14, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
4 Insider transaction Mar 6, 2026 Mar 5, 2026
144 Notice of proposed sale Mar 5, 2026 —
S-8 Employee stock plan registration Mar 2, 2026 —
S-3ASR Automatic shelf registration Mar 2, 2026 —
10-K Annual report Mar 2, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 2, 2026 Mar 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Jan 26, 2026 Jan 22, 2026
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
144 Notice of proposed sale Dec 5, 2025 —
4 Insider transaction Nov 26, 2025 Nov 24, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 24, 2025 —
4 Insider transaction Nov 24, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 21, 2025 —
144 Notice of proposed sale Nov 21, 2025 —
144 Notice of proposed sale Nov 21, 2025 —
144 Notice of proposed sale Nov 21, 2025 —
144 Notice of proposed sale Nov 20, 2025 —
144 Notice of proposed sale Nov 20, 2025 —
144 Notice of proposed sale Nov 20, 2025 —
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 19, 2025 —
144 Notice of proposed sale Nov 19, 2025 —
144 Notice of proposed sale Nov 19, 2025 —
144 Notice of proposed sale Nov 19, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 7, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 31, 2025 —
4 Insider transaction Oct 28, 2025 Oct 24, 2025
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 24, 2025 —
144 Notice of proposed sale Oct 24, 2025 —
144 Notice of proposed sale Oct 24, 2025 —
144 Notice of proposed sale Oct 24, 2025 —
4 Insider transaction Oct 22, 2025 Oct 21, 2025
4 Insider transaction Oct 21, 2025 Oct 21, 2025
144 Notice of proposed sale Oct 21, 2025 —
144 Notice of proposed sale Oct 21, 2025 —
144 Notice of proposed sale Oct 21, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 20, 2025 —
4 Insider transaction Oct 20, 2025 Oct 16, 2025
144 Notice of proposed sale Oct 20, 2025 —
144 Notice of proposed sale Oct 20, 2025 —
4 Insider transaction Oct 17, 2025 Oct 15, 2025
144 Notice of proposed sale Oct 17, 2025 —
144 Notice of proposed sale Oct 17, 2025 —
144 Notice of proposed sale Oct 16, 2025 —
144 Notice of proposed sale Oct 16, 2025 —
144 Notice of proposed sale Oct 16, 2025 —
4 Insider transaction Oct 15, 2025 Oct 10, 2025
144 Notice of proposed sale Oct 15, 2025 —
144 Notice of proposed sale Oct 14, 2025 —
144 Notice of proposed sale Oct 14, 2025 —
144 Notice of proposed sale Oct 10, 2025 —
144 Notice of proposed sale Oct 10, 2025 —
4 Insider transaction Oct 7, 2025 Oct 3, 2025
144 Notice of proposed sale Oct 6, 2025 —
144 Notice of proposed sale Oct 6, 2025 —
144 Notice of proposed sale Oct 3, 2025 —
144 Notice of proposed sale Oct 3, 2025 —
4 Insider transaction Oct 3, 2025 Oct 1, 2025
3 Initial insider ownership Oct 3, 2025 Oct 1, 2025
4 Insider transaction Oct 1, 2025 Sep 29, 2025
144 Notice of proposed sale Oct 1, 2025 —
144 Notice of proposed sale Oct 1, 2025 —
144 Notice of proposed sale Sep 30, 2025 —
144 Notice of proposed sale Sep 30, 2025 —
4 Insider transaction Sep 30, 2025 Sep 26, 2025
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 26, 2025 —
4 Insider transaction Sep 5, 2025 Sep 4, 2025
144 Notice of proposed sale Sep 4, 2025 —
4 Insider transaction Sep 3, 2025 Aug 29, 2025
4 Insider transaction Aug 28, 2025 Aug 26, 2025
4 Insider transaction Aug 28, 2025 Aug 26, 2025
144 Notice of proposed sale Aug 26, 2025 —
144 Notice of proposed sale Aug 26, 2025 —
4 Insider transaction Aug 21, 2025 Aug 20, 2025
4 Insider transaction Aug 21, 2025 Aug 19, 2025
144 Notice of proposed sale Aug 20, 2025 —
144 Notice of proposed sale Aug 20, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 30, 2025 —
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Jun 16, 2025 —
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
8-K Current report
Regulation FD disclosure
Jun 4, 2025 Jun 4, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 12, 2025
3 Initial insider ownership Apr 1, 2025 Apr 1, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
SCHEDULE 13D Ownership over 5% (active) Feb 18, 2025 —
SCHEDULE 13D Ownership over 5% (active) Feb 18, 2025 —
SCHEDULE 13D Ownership over 5% (active) Feb 18, 2025 —
SCHEDULE 13D Ownership over 5% (active) Feb 18, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13D Ownership over 5% (active) Feb 13, 2025 —
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 10, 2025 Feb 10, 2025
4 Insider transaction Feb 10, 2025 Feb 10, 2025
4 Insider transaction Feb 10, 2025 Feb 6, 2025
4 Insider transaction Feb 10, 2025 Feb 6, 2025
4 Insider transaction Feb 10, 2025 Feb 6, 2025
4 Insider transaction Feb 10, 2025 Feb 6, 2025
4 Insider transaction Feb 10, 2025 Feb 10, 2025
4 Insider transaction Feb 10, 2025 Feb 10, 2025
4 Insider transaction Feb 10, 2025 Feb 10, 2025
4 Insider transaction Feb 10, 2025 Feb 6, 2025
8-K Current report
Bylaw or fiscal year change
Feb 10, 2025 Feb 6, 2025
S-8 Employee stock plan registration Feb 7, 2025 —
424B4 Prospectus Feb 7, 2025 —
SEC STAFF LETTER Filing Feb 6, 2025 —
EFFECT Filing Feb 6, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SION (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
, Emerging growth company
SEC CIK
2036042

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.